Efficacy of SGLT2-inhibitors across different definitions of heart failure with preserved ejection fraction.

Vincenzo De MarzoGianluigi SavareseItalo PortoMarco MetraPietro Ameri

Published in: Journal of cardiovascular medicine (Hagerstown, Md.) (2023)

In RCTs, SGLT2i improved the outcomes of patients with HFpEF regardless of how the latter was diagnosed.

Keyphrases